+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Europe Arachidonic Acid Market - Growth, Trends And Forecasts (2019 - 2024)

  • PDF Icon


  • 80 Pages
  • May 2019
  • Region: Europe
  • Mordor Intelligence
  • ID: 4544634
UP TO OFF until Sep 30th 2023
Market Overview

Europe Arachidonic Acid Market report is forecasted to reach USD 56 million by 2024 growing at a CAGR of 6.0% during the forecast period (2019 - 2024).
  • Europe is the second largest consumer of arachidonic acid in the world. The market is growing for arachidonic acid, as the consumers are looking for a healthy dietary supplement.
  • The drivers for the ARA market is increased demand for infant nutrition products containing ARA, increased application in sports nutrition, various health benefits of ARA and the government approval for incorporation into infant products. The important function properties of ARA are increasing the consumer demand for arachidonic acid in Europe as a functional food.
  • The declining birth rate in the region is the major restraining factor for the market. Europe is expected to grow at a steady growth rate during the forecast period.

Scope of the Report

The arachidonic acid market is distributed in a different segment on the application type, and by geography. In the application type, the arachidonic acid market is segmented into two major applications, namely, food & beverage and pharmaceutical. The food & beverage segment is further divided into infant formula and dietary supplements. Among food & beverage sub-segments, infant nutrition holds the dominant share of the market and being driven by regulatory support.

Key Market Trends

Infant Nutrition Holds The Dominant Share

Infant formula and dietary supplement are the major applications of ARA in the European market. Infant formula accounts for the largest application, while fortified foods and beverages are growing at a faster rate in Europe. The ARA market was first discovered in the European market due to less exposure to technology and R&D activities by the European companies made the intervention of US companies to gain higher market penetration. Europe has tightened regulatory environment related to pharmaceutical and food products especially the when ARA is added in infant formula, the permissible level that is allowed is no more than 0.35% and 0.6% of the total fatty acids as DHA and ARA.

Germany and UK Dominates The Market

The German ARA market growing at a rate of CAGR of 5.9%. With new innovations in the applications of arachidonic acid, especially in pharma and supplement applications, is driving the market in Germany. Major factors affecting the UK ARA market are increasing applications of Omega 6 fatty acids, such as usage in dietary supplements and supporting regulations of the European Commission for ARA. The consumption pattern of consumers for natural foods, such as fish, egg, beef, etc., containing ARA, enables market players to come up with dietary supplements with ARA as an ingredient. However, Spain also has a significant share of ARA in Europe, with the potential for market growth. Moreover, Russia is one of the most attractive markets for ARA & DHA in Europe due to increased consumption of infant formula and baby food products. Other countries in Europe, with significant markets for ARA are Norway, Finland, Sweden, Iceland, Portugal and Ireland.

Competitive Landscape

Major Players: DSM, BASF, Cargill, Martek Bioscience, Cabio Bioengineering, Guangdong Runke, Cayman Chemicals, A&Z Food additives Co. Ltd., Zhejiang Weiss (Wecan), and Kingdomway, among others. Advancement in biotechnology has given a good opportunity for the market. The microbiological source of production is giving a new opportunity for the market, as ARA is present in high concentration in microalgae. The production ARA from other sources than fungal is a big challenge for the market, due to its high raw material cost and wastage. The major competitors prefer investment in new product development and marketing strategy, due to volatility in commodity costs to maintain their position.

This product will be delivered within 2 business days.

Table of Contents

1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
3.1 Market Overview
4.1 Market Drivers
4.2 Market Restraints
4.3 Porter's Five Forces Analysis
4.3.1 Threat of New Entrants
4.3.2 Bargaining Power of Buyers/Consumers
4.3.3 Bargaining Power of Suppliers
4.3.4 Threat of Substitute Products
4.3.5 Intensity of Competitive Rivalry
5.1 By Technology
5.1.1 Solvent Extraction
5.1.2 Solid-Phase Extraction
5.2 By Application
5.2.1 Food and Beverage Infant Formula Dietary Supplements
5.2.2 Pharmaceuticals
5.3 Geography
5.3.1 Europe Germany United Kingdom France Russia Spain Italy Rest of Europe
6.1 Market Share Analysis
6.2 Company Profiles
6.2.1 Cargill. Inc
6.2.2 Cabio Biotech (Wuhan)Co., Ltd
6.2.3 Xiamen Kingdomway
6.2.4 Cayman Chemicals
6.2.5 Martek Bioscience
6.2.6 Guangdong Runke Bioengineering Co., Ltd.
6.2.7 Royal DSM
6.2.8 A & Z Food Additives Co., Ltd
6.2.9 Zhejiang Weiss (Wecan)
6.2.10 BASF

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Cargill. Inc
  • Cabio Biotech (Wuhan)Co., Ltd
  • Xiamen Kingdomway
  • Cayman Chemicals
  • Martek Bioscience
  • Guangdong Runke Bioengineering Co., Ltd.
  • Royal DSM
  • A & Z Food Additives Co., Ltd
  • Zhejiang Weiss (Wecan)
  • BASF